Why UBS believes markets under-appreciate Aquaguard-maker Eureka Forbes

UBS initiated coverage on Eureka Forbes with a 'Buy' call, identifying it as a 'steady earnings compounder' with under-appreciated scale advantages in water purifiers and services. The brokerage set a target price of Rs 640, citing market growth driven by health awareness and expanding consumer base.